Steady-state and dynamic behavior of ventricular repolarization and refractoriness in the dog: The effect of multiple cycle length changes and d- sotalol administration

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 9, 1998, Pages 1766-1777

  Leerssen, Hendrik M ^a,c   Vos, Marc A ^a   Den Dulk, Karel ^a   Van Der Zande, Jolanda ^a   Muijtjens, Arno M M ^a   Begemann, Malcolm J ^b   Wellens, Hein J J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Vitatron BV   (Netherlands)

^c St Jude Medical   (Netherlands)

Author keywords

Action potential duration; Bi exponential repolarization dynamics; On line monitoring of repolarization and refractoriness; Stimulus T interval; Ventricular effective refractory period

Indexed keywords

SOTALOL;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ARTICLE; ATRIOVENTRICULAR BLOCK; DOG; DRUG EFFECT; HEART HEMODYNAMICS; HEART RATE; NONHUMAN; REFRACTORY PERIOD;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIAC PACING, ARTIFICIAL; DOGS; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART BLOCK; HEART VENTRICLES; MALE; ONLINE SYSTEMS; SIGNAL PROCESSING, COMPUTER-ASSISTED; SOTALOL;

EID: 0031663572     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb00277.x     Document Type: Article

References (37)

1. Janse MJ, van der Steen ABM, van Dam RT, et al. Refractory period of the dog's ventricular myocardium following sudden changes in frequency. Circ Res 1969; 24:251-262.
2. Han J, Moe GK. Cumulative effects of cycle length on refractory periods in cardiac tissue. Am J Physiol 1969; 217:106-109.
3. Wellens HJJ. Value and limitations of programmed electrical stimulation of the heart in the study and treatment of tachycardias. Circulation 1978; 57:845-853.
4. Franz MR, Swerdlow CD, Liem LB, et al. Cycle length dependence of human action potential duration in vivo. J Clin Invest 1988; 82:972-979.
5. Rickards AF, Norman J. Relation between QT interval and heart rate. New design of physiologically adaptive cardiac pacemaker. Br Heart J 1981; 45:56-61.
6. Morady F, Kadish AH, Toivonen LK, et al. The maximum effect of an increase in rate on human ventricular refractoriness. PACE 1988; 11: 2223-2234.
7. Wiener I, Kunkes S, Rubin D, et al. Effects of sudden change in cycle length on human atrial, atrioventricular nodal and ventricular refractory periods. Circulation 1981; 64(2):245-248.
8. Brownstein SL, Blackwell WH, Welch WJ, et al. Cumulative effects of cycle length on ventricular refractoriness in man. Am Heart J 1990; 119:324-330.
9. Boyett MR, Jewell BR. A study of the factors responsible for rate-dependent shortening of the action potential in mammalian ventricular muscle. J Physiol 1978; 285:359-380.
10. Franz MR, Platia EV, Schaefer J, et al. Fast and slow adaptation of human monophasic action potentials to abrupt changes in heart rate. (abstract) Am J Cardiol 1982; 49:970.
11. Franz MR. Long-term recording of monophasic action potentials from human endocardium. Am J Cardiol 1983; 51:1629-1634.
12. Kanaan N, Jenkins J, Childs K, et al. Monophasic action potential duration during programmed electrical stimulation. PACE 1991; 14:1049-1059.
13. Rosenbaum DS, Kaplan DT, Kanai A, et al. Repolarization inhomogeneities in ventricular myocardium change dynamically with abrupt cycle length shortening. Circulation 1991; 84: 1333-1345.
14. Lau CP, Freedman AR, Fleming S, et al. Hysteresis of the ventricular paced QT interval in response to abrupt changes in pacing rate. Cardiovasc Res 1988; 22:67-72.
15. Millar CK, Kralios FA, Lux RL. Correlation between refractory periods and activation-recovery intervals from electrograms: Effects of rate and adrenergic interventions. Circulation 1985; 72(6):1372-1379.
16. Haws CW, Lux RL. Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms. Circulation 1990; 81:281-288.
17. Manley BS, Chong EMF, Walton C, et al. An animal model for the chronic study of ventricular repolarisation and refractory period. Cardiovasc Res 1989; 23:16-20.
18. Morgan JM, Cunningham AD, Rowland E. Relationship of the effective refractory period and the monophasic action potential duration after a step increase in pacing frequency. PACE 1990; 13:1002-1008.
19. Taggert P, Sutton P, Donaldson R. d-sotalol: A new potent class III anti-arrhythmic agent. Clin Sci 1985; 69:631-636.
20. Schmitt C, Brachmann J, Karch M, et al. Reverse use-dependent effects of sotalol demonstrated by recording monophasic action potentials of the right ventricle. Am J Cardiol 1991; 68:1183-1187.
21. Huikuri HV, Yli-Mäyry S. Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle. PACE 1992; 15(Pt. II):2103-2107.
22. Ruffy R. Sotalol. J Cardiovasc Electrophysiol 1993; 4:81-98.
23. Scherlag BJ, Kosowsky BD, Damato AN. A technique for ventricular pacing from the His bundle in the intact heart. J Appl Physiol 1967; 22:584-587.
24. Morady F, Kadish AH, Rosenheck S, et al. Effect of the intertrain pause on the ventricular effective refractory period measured by the extrastimulus technique. PACE 1990; 13:405-409.
25. Leerssen HM, Vos MA, den Dulk K, et al. Is the ventricular effective refractory period different when determined by incremental versus decremental scanning? The effect of pacing cycle length, d-sotalol and levcromakalim. PACE 1994; 17(Pt. II):2084-2089.
26. Edvardsson N, Hirsch I, Olsson SB. Right ventricular monophasic action potentials in healthy young men. PACE 1984; 7:813-821.
27. Baig MW, Boute W, Begemann M, et al. Nonlinear relationship between pacing and evoked QT intervals. PACE 1988; 11:753-759.
28. Leerssen HM, Vos MA, den Dulk K, et al. Inter- and intraindividual variations in shortening of ventricular effective refractory period after an abrupt decrease in pacing cycle length. PACE 1994; 17(Pt. II):2079-2083.
29. Efimow IR, Huang DT, Rendt JM, et al. Optical mapping of repolarization and refractoriness from intact hearts. Circulation 1994; 90:1469-1480.
30. Kanai A, Salama G. Optical mapping reveals that repolarization spreads anisotropically and is guided by fiber orientation in guinea pig hearts. Circ Res 1995; 77:784-802.
31. Marchlinski FE. Characterization of oscillations in ventricular refractoriness in man after an abrupt increment in heart rate. Circulation 1987; 75(3):550-556.
32. Verduyn SC, Vos MA, van der Zande J, et al. Biventricular hypertrophy facilitates occurrence of acquired torsade de pointes arrhythmias in dogs. (abstract) Circulation 1995; 92(8):504-505.
33. Denardo SJ, Stevenson WG. Is the adaptation of right ventricular refractoriness to an abrupt increase in heart rate impaired in chronic heart failure? Am Heart J 1989; 117:585-589.
34. Donaldson RM, Rickards AF. Evaluation of drug-induced changes in myocardial repolarisation using the paced evoked response. Br Heart J 1982; 48:381-387.
35. Donaldson RM, Taggert P, Swanton H, et al. Intracardiac electrode detection of early ischaemia in man. Br Heart J 1983; 50:213-221.
36. Belz MK, Ellenbogen KA, Camm AJ, et al. Differentiation between monomorphic ventricular tachycardia and sinus tachycardia based on the right ventricular evoked potential. PACE 1992; 15(Pt. I):1661-1666.
37. Bolz A, Hardt R, Hubmann M, et al. A new autocapture logic based on fractally coated low polarization pacing leads. (abstract) PAGE 1993; 16:1914.